P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT-NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS

• I. Johnson,
• K. McCullough,
• F. Farrukh,
• A. Al-Kali,
• H. Alkhateeb,
• K. Begna,
• A. Mangaonkar,
• M. Litzow,
• W. Hogan,
• M. Shah,
• M. Patnaik,
• A. Pardanani,
• A. Tefferi,
• N. Gangat

Affiliations

I. Johnson

1 Department of Medicine

K. McCullough

2 Divison of Hematology

F. Farrukh

3 Mayo Clinic, Rochester, United States of America

A. Al-Kali

3 Mayo Clinic, Rochester, United States of America

H. Alkhateeb

3 Mayo Clinic, Rochester, United States of America

K. Begna

3 Mayo Clinic, Rochester, United States of America

A. Mangaonkar

3 Mayo Clinic, Rochester, United States of America

M. Litzow

3 Mayo Clinic, Rochester, United States of America

W. Hogan

3 Mayo Clinic, Rochester, United States of America

M. Shah

3 Mayo Clinic, Rochester, United States of America

M. Patnaik

3 Mayo Clinic, Rochester, United States of America

A. Pardanani

3 Mayo Clinic, Rochester, United States of America

A. Tefferi

3 Mayo Clinic, Rochester, United States of America

N. Gangat

3 Mayo Clinic, Rochester, United States of America